Public research preview

Carol Devine Miller, Representative disclosure: Quest Diagnostics Incorporated Common Stock (DGX)

Disclosed a buy transaction in Quest Diagnostics Incorporated Common Stock (DGX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
13 Dec 2022, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
29 days

Timeline

Transaction date

14 Nov 2022

Public disclosure

13 Dec 2022

Now

Tracked today

Filing delay: 29 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Stock path

DGX from pre-transaction context through latest close.

Bought

14 Nov 2022 · 140.314 USD · Not public yet

System decision

Would have boughtThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 13 Dec 2022 at 139.726 USD. Since entry: +41.1%. Planned exit on 10 Feb 2023 after 40 trading days.

Window closed114.5162.7211USDDate14 Nov13 Dec8 JunOfficial disclosure13 DecPlanned exit139.7System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
140.314
Observed disclosure close
139.726
Observed latest close
197.21
Pre-disclosure move
-0.4%
Post-disclosure move
+41.1%
Market-adjusted move
+41.1%
1w since disclosure
+0.3%
1m since disclosure
-1.1%
3m since disclosure
-10.7%
Pre-disclosure peak run-up
+1.5%
Retrace from peak
-1.9%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 13 Dec 2022, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerDGX
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20022133.pdf
personNameCarol Devine Miller
amountRange$1,001 - $15,000
companyNameQuest Diagnostics Incorporated (DGX)
publishedAt2022-12-13T00:00:00.000Z
rawDocumentIdraw-us-house-20022133-10
disclosureDate2022-12-13
transactionDate2022-11-14
transactionTypeP